Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKRO
201
DELISTED
Akero Therapeutics
AKRO
| $146M | 0.1% |
3,811,676
+471,502
| +14% | +$21M |
|
202
Aptiv
APTV
$10.1B
| $145M | 0.1% |
1,295,162
+28,005
| +2% | +$3.09M |
|
203
Dollar Tree
DLTR
$25.1B
| $145M | 0.1% |
1,010,133
+284,619
| +39% | +$41.3M |
|
204
Cullen/Frost Bankers
CFR
$10.2B
| $145M | 0.1% |
1,372,950
+122,118
| +10% | +$15.2M |
|
205
HCA Healthcare
HCA
$89.8B
| $145M | 0.1% |
548,094
+519,398
| +1,810% | +$132M |
|
206
Cencora
COR
$62B
| $143M | 0.09% |
891,543
-64,115
| -7% | -$10.2M |
|
207
Ambev
ABEV
$45.7B
| $140M | 0.09% |
49,829,560
+1,082,525
| +2% | +$2.83M |
|
208
Vanguard Total International Stock ETF
VXUS
$162B
| $140M | 0.09% |
2,538,677
-27,024
| -1% | -$1.48M |
|
209
Clean Harbors
CLH
$16.5B
| $140M | 0.09% |
982,820
+972,802
| +9,711% | +$127M |
|
210
PagerDuty
PD
$912M
| $138M | 0.09% |
3,945,046
+30,116
| +0.8% | +$884K |
|
211
Ryan Specialty Holdings
RYAN
$10.9B
| $136M | 0.09% |
3,375,525
-548,076
| -14% | -$22.5M |
|
212
CBRE Group
CBRE
$42B
| $134M | 0.09% |
1,841,979
+502,621
| +38% | +$41.1M |
|
213
Gilead Sciences
GILD
$165B
| $133M | 0.09% |
1,606,756
-431,194
| -21% | -$35.7M |
|
214
Brady Corp
BRC
$4.57B
| $133M | 0.09% |
2,480,744
-257,214
| -9% | -$13.5M |
|
215
SkinHealth Systems
SKIN
$84.1M
| $133M | 0.09% |
10,546,990
+257,885
| +3% | +$2.98M |
|
216
Salesforce
CRM
$160B
| $133M | 0.09% |
665,420
+34,585
| +5% | +$5.84M |
|
217
TransUnion
TRU
$15.2B
| $129M | 0.09% |
2,081,060
+2,055,357
| +7,997% | +$135M |
|
218
NeoGenomics
NEO
$2.14B
| $129M | 0.09% |
7,424,352
+1,298,581
| +21% | +$18.5M |
|
219
Mercado Libre
MELI
$93.2B
| $129M | 0.09% |
97,805
-38,993
| -29% | -$44.4M |
|
220
Welltower
WELL
$170B
| $127M | 0.08% |
1,779,085
+61,887
| +4% | +$4.49M |
|
221
Frontdoor
FTDR
$5.88B
| $126M | 0.08% |
4,536,603
-372,789
| -8% | -$9.85M |
|
222
Alexandria Real Estate Equities
ARE
$8.35B
| $126M | 0.08% |
1,006,653
+136,960
| +16% | +$20.1M |
|
223
Waters Corp
WAT
$40.4B
| $119M | 0.08% |
382,881
-21,556
| -5% | -$6.97M |
|
224
Cummins
CMI
$88.2B
| $118M | 0.08% |
495,750
+418,718
| +544% | +$102M |
|
225
Williams Companies
WMB
$86.8B
| $117M | 0.08% |
3,926,980
+37,184
| +1% | +$1.15M |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.